These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 385637)

  • 21. [Comparison of exercise tolerance in hypertensive patients treated with atenolol and methyldopa].
    Ambrosioni E; Costa FV; Agosta R; Magnani B
    G Clin Med; 1979 Aug; 60(8):676-83. PubMed ID: 398306
    [No Abstract]   [Full Text] [Related]  

  • 22. Double blind cross-over study comparing prazosin and methyldopa in the treatment of mild hypertension.
    Verhiest W; Croonenberghs J; Devos P; Fagard R; Amery A
    Acta Cardiol; 1974; 29(3):217-33. PubMed ID: 4601854
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
    Barritt DW; Marshall AJ; Heaton S
    Lancet; 1976 Mar; 1(7958):503-5. PubMed ID: 55780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication.
    Lepäntalo M
    Br J Clin Pharmacol; 1984 Jul; 18(1):90-3. PubMed ID: 6378235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sotalol in angina pectoris. A double-blind study.
    Slome R
    S Afr Med J; 1976 Mar; 50(12):469-72. PubMed ID: 818720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M
    Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
    [No Abstract]   [Full Text] [Related]  

  • 27. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
    Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract]   [Full Text] [Related]  

  • 29. Synergism of a beta blocker and a diuretic in the once-a-day treatment of essential hypertension.
    Basson W; Myburgh DP
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):571-8. PubMed ID: 385640
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of clonidine and methyldopa in hypertensive patients receiving a diuretic. A double-blind crossover study.
    Mroczek WJ; Leibel BA; Finnerty FA
    Am J Cardiol; 1972 May; 29(5):712-7. PubMed ID: 4553738
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of efficacy and safety of pindolol and alpha-methyldopa in treatment of mild to moderate hypertension: results of a double-blind evaluative study.
    Beanlands DS; Allard PP; Wilson M; Orbeck KW; Helman AB; Lefebvre R
    Clin Invest Med; 1978; 1(3-4):139-45. PubMed ID: 391453
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension.
    Planz G; Gierlichs HW; Hawlina A; Planz R; Stephany W; Rahn KH
    Eur J Clin Pharmacol; 1977 Dec; 12(4):241-5. PubMed ID: 338308
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
    Whelton PK; Russell RP; Sova-Schulz K; Wyndham R; Walker WG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S28-37. PubMed ID: 94637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of exercise in hypertension controlled with metoprolol or methyldopa.
    Stoker JB; Sreeharan N; Linden RJ; Barbour MP; Lorimer AR; Hillis WS; Lawrie TD
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():391s-392s. PubMed ID: 540459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of alprenolol and methyldopa in previously untreated essential hypertension.
    Vedin JA; Wilhelmsson CE; Werkö L
    Br Heart J; 1973 Dec; 35(12):1285-92. PubMed ID: 4586374
    [No Abstract]   [Full Text] [Related]  

  • 37. Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension.
    Routledge PA; Zrinzo LV; Rao JG; Walden RJ; Davies DM; Rawlins MD
    Eur J Clin Pharmacol; 1977 Mar; 11(3):159-62. PubMed ID: 323023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atenolol and methyldopa in the treatment of hypertension.
    Wilson C; Scott ME; Abdel-Mohsen A
    Postgrad Med J; 1977; 53 Suppl 3():123-7. PubMed ID: 337266
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind study of trimazosin and methyldopa in hypertensive patients receiving polythiazide.
    Moyer RR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1250-3. PubMed ID: 6356853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.